Design Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Carlsbad, CA
DSGN chart
What traders are saying about $DSGN
Latest postsDesign Therapeutics, Inc. news
- Weekly Recap: Q3 loss and DT-818 Phase 1 dosing begins
TradingView ·
- RBC Capital Maintains Design Therapeutics(DSGN.US) With Buy Rating, Cuts Target Price to $19
Moomoo ·
- Design Therapeutics (DSGN) Stock Price, Chart & Analysis
www.debelegger.nl ·
- RBC Capital maintains Design Therapeutics at Outperform, lowers price target to $19 from $20
TradingView ·
- RBC Cuts Price Target on Design Therapeutics to $19 From $20, Keeps Outperform, Speculative Risk
marketscreener.com ·
- Design Therapeutics, Inc. Stock 12‑Month Price Target Cut to $21.57, Implies 103% Upside
TradingView ·
- Design Therapeutics authorizes $200M stock sales through Jefferies
scanx.trade ·
- With $208.6M in cash and investments, Design Therapeutics (DSGN) posts a wider Q3 loss.
Stock Titan ·
- Design Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Design Therapeutics Q3 net loss beats estimates; sees DT-216P2 data in Q1
TradingView ·
- Design Therapeutics Reports Q3 2026 Results, $208.6 Million in Cash and Securities
TradingView ·
- DESIGN THERAPEUTICS Q3 NET INCOME USD -20.288 MILLION VS. IBES ESTIMATE USD -21.8 MILLION
Moomoo ·
Design Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | – | – |
| Net income | -$69.8M | -$49.6M | -$66.9M | -$63.3M |
| Diluted EPS | $-1.22 | $-0.88 | $-1.19 | $-1.14 |
| Total assets (year end) | $226.2M | $252.1M | $289.6M | $341.1M |
| Cash and equivalents (year end) | $16.9M | $22.6M | $21.2M | $26.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Design Therapeutics, Inc.
- Ticker
- DSGN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Carlsbad, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1807120
Frequently asked questions
What exchange is Design Therapeutics, Inc. listed on?
Design Therapeutics, Inc. trades on the Nasdaq under the ticker symbol DSGN.
What industry is Design Therapeutics, Inc. in?
Design Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Design Therapeutics, Inc. headquartered?
Design Therapeutics, Inc.'s business address on file with the SEC is in Carlsbad, CA.
When does Design Therapeutics, Inc.'s fiscal year end?
Design Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Design Therapeutics, Inc. report?
Design Therapeutics, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.